Skip to content

Caricef Suspension

Caricef Suspension (Cefixime Trihydrate) USP specs by Sami 100mg/5ml strength granule, for oral suspension of 30ml (after reconstitution). Shake well before use. It is used to treat susceptible bacterial infections, including ear infections and throat infections.

Package Contains: Each Caricef package contains a 30ml suspension (syrup) bottle, when reconstituted, in a strength of 100mg/5ml & a leaflet. Caricef Suspension

Composition: (Cefixime for Oral Suspension, USP)

Each 5ml contains (reconstituted):

Cefixime Trihydrate USP eq. to Cefixime 100mg

Dosage: Children: The recommended dosage for children is 8mg/kg/day administered as a single dose.

Usual dosage is as under:

1 – 4 years: 1 teaspoonful once a day.

5 – 9 years: 2 teaspoonfuls once a day.

10 – 12 years: 3 teaspoonfuls once a day.

Or as directed by the physician.

Directions for reconstitution: Shake the bottle to loosen the mass. Add freshly boiled and cooled water below the mark given on the bottle label, then shake to make a homogeneous suspension. Add further the same water upto the mark on the bottle label and shake vigorously to form a uniform suspension.

Therapeutic Indications: Cefixime is an orally active cephalosporin antibiotic which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms. It is indicated for the treatment of the following acute infections when caused by susceptible micro-organisms:

  • Upper respiratory tract infections (URTIs): e.g. otitis media, and other URTIs where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk.
  • Lower respiratory tract infection: e.g. bronchitis.
  • Urinary tract infections: e.g. cystitis, cystourethritis, uncomplicated pyelonephritis.
  • Clinical efficacy has been demonstrated in infections caused by commonly occurring pathogens including Streptococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Branhamella catarrhalis (beta-lactamase positive and negative) and Enterobacter species.
  • Uncomplicated Gonorrhoea (cervical/urethral): Caused by Neisseria gonorrhoeae (penicillinase and non-penicillinase producing isolates).
  • Cefixime is highly stable in the presence of beta-lactamase enzymes.
  • Most strains of Enterococci (Streptococcus faecalis, group D Streptococci) and Staphylococci (including coagulase-positive and negative strains and methicillin-resistant strains) are resistant to cefixime.
  • In addition, most strains of Pseudomonas, Bacteroides fragilis, Listeria monocytogenes and Clostridia are resistant to cefixime.

Adverse Reactions: Severe cutaneous adverse reactions (SCARs) including toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), and acute generalised exanthematous pustulosis (AGEP) have been reported in association with cefixime. Patients should be informed about the signs and symptoms of serious skin manifestations and monitored closely. Treatment should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of skin hypersensitivity. it should be given with caution to patients who have shown hypersensitivity to other drugs.

Paediatric use: Safety of cefixime in premature or newborn infants has not been established.

Contraindication: Cefixime is contraindicated in patients with known allergy to cefixime or other cephalosporins.

Instruction:

  • For oral use only. Tightly close the cap after use.
  • Keep out of reach of children.
  • Avoid exposure to heat, light and humidity.
  • Do not store over 30°C.
  • Improper storage may deteriorate the medicine.
  • The reconstituted suspension should be kept at 2 – 8°C so that the potency of the product remains stable and should be used within 7 days.
  • Only to be sold on prescription of a registered medical practitioner.

Manufacturer & Buy Online: Caricef Suspension back

Caricef suspension is manufactured by: Healthtek (Pvt.) Limited.

This is the link to the manufacturer: https://healthtek

Caricef suspension is manufactured for: SAMI Pharmaceuticals (Pvt.) Ltd.

This is the link to the company: https://samipharma

You can buy it online at:  https://www.dvago.pk

It is available online, or you can buy it from any nearby pharmacy. It is currently (2026) available at the retail price of around 276 rupees.

 

By: Urooj

 

Tags: